2020 annual financial data
Seres Therapeutics 2020 Operating margin
Seres Therapeutics 2020 operating margin with verified reported values.
Direct answer
Operating margin was -265.33%.
Operating income was -88,130,000 USD and net income was -89,127,000 USD.
Operating cash flow was -93,610,000 USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,215,000 USD
- Operating income
- -88,130,000 USD
- Net income
- -89,127,000 USD
- Operating cash flow
- -93,610,000 USD